JP Morgan analyst Doug Anmuth downgrades Netflix (NASDAQ:NFLX) from Overweight to Neutral and announces $300 price target.
UBS Maintains Neutral on Amgen, Raises Price Target to $238
UBS maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $194 to $238.